BIOLOGICAL INTELLIGENCE
Live / Applied — Statement of use — final refusal mailed (as of 27 Oct 2025)
What this means for you
Not registered yet, but its 01 Feb 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90501374
- Mark type
- Stylized text
- Filed
- 01 Feb 2021
- Published for opposition
- 26 Apr 2022
- Attorney of record
- Francis P. Cislak
Goods and services
- Class 001 — Chemicals: biochemical, namely, monoclonal antibodies for use in scientific and medical research
- Class 031 — Natural agricultural products: live laboratory animals
- Class 042 — Scientific and technological services: scientific research and development; scientific research and development in the field of immunization and antibody screening
Owner
- OMNIAB, INC., Emeryville, CA, US
- Open Monoclonal Technology, Inc., Emeryville, CA, US
- Open Monoclonal Technology, Inc., Emeryville, CA, US
Prosecution history
- 08 Jan 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 08 Jan 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 27 Oct 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 27 Oct 2025 — FINAL REFUSAL E-MAILED
- 27 Oct 2025 — SU - FINAL REFUSAL - WRITTEN
- 24 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Oct 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 Oct 2025 — ASSIGNED TO LIE
- 14 Oct 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 15 Jul 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 15 Jul 2025 — NON-FINAL ACTION E-MAILED
- 15 Jul 2025 — SU - NON-FINAL ACTION - WRITTEN
- 03 Jul 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 16 Jun 2025 — USE AMENDMENT FILED
- 16 Jun 2025 — TEAS STATEMENT OF USE RECEIVED